Aspira Women's Health enters $10M equity purchase agreement with Lincoln Park Capital

Aspira Women's Health Inc.

Company can sell up to $10M of common stock to Lincoln Park over 36 months at its discretion.
Pricing based on market price with discount; regular purchases up to 100k-300k shares per day depending on stock price.
Commitment fee of 715,990 shares issued to Lincoln Park; no cash proceeds from those shares.
Proceeds to be used for product pipeline development, working capital, and general corporate purposes.
Lincoln Park prohibited from short selling or hedging; company can terminate agreement at any time without penalty.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Aspira Women's Health Inc. entered into Purchase Agreement with Lincoln Park Capital Fund, LLC valued at up to $10,000,000 (effective 2023-03-28).

Action: entry
Agreement: equity purchase
Counterparty: Lincoln Park Capital Fund, LLC
Value: up to $10,000,000
Effective: 2023-03-28

Exact text from the filing

On March 28 , 202 3, Aspira Women’s Health Inc. (the “Company”) and Lincoln Park Capital Fund, LLC (“Lincoln Park”) entered into a purchase agreement (the “Purchase Agreement”)

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Aspira Women's Health Inc. entered into Registration Rights Agreement with Lincoln Park Capital Fund, LLC (effective 2023-03-28).

Action: entry
Counterparty: Lincoln Park Capital Fund, LLC
Effective: 2023-03-28

Exact text from the filing

(the “Company”) and Lincoln Park Capital Fund, LLC (“Lincoln Park”) entered into a purchase agreement (the “Purchase Agreement”) and a registration rights agreement (the “Registration Rights Agreement”), pursuant to which the Company has the right, in its sole discretion, to sell to Lincoln Park shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), having an aggregate value of up to $10,000,000 (the “Purchase Shares”), subject to certain limitations and conditions set forth in the Purchase Agreement.

View on SEC.gov

85 material agreements filed in the last 30 days. Browse all material agreements →

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0000926617-23-000024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.